Bupivacaine plus lidocaine versus bupivacaine alone for ultrasound-guided popliteal sciatic nerve block
Official title: Bupivacaine-Lidocaine Combination Versus Bupivacaine Alone for Ultrasound-Guided Popliteal Sciatic Nerve Block in Elective Lower Extremity Surgery: A Prospective Randomized Double-Blind Trial
Run by Ataturk University · NCT07550348 · Data updated 2026-11-12
This trial will test whether adding lidocaine to bupivacaine gives faster numbness and longer-lasting pain relief for adults having below-knee (foot or ankle) surgery with an ultrasound-guided popliteal sciatic nerve block.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Ataturk University Academic / other |
| Locations | 1 site (Erzurum) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | March 1, 2027 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT07550348 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 years old with ASA physical status I–III, BMI 18–35 kg/m², scheduled for elective below-knee lower extremity surgery, who can give informed consent and have no contraindications to local anesthetics are ideal candidates.
✕Probably not a fit
Patients with known allergy to local anesthetics, severe cardiac/hepatic/renal disease, pre-existing peripheral neuropathy, pregnancy, BMI ≥35, active anticoagulant therapy, prior popliteal surgery/scar, or chronic home opioid use are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, double-blind, single-center trial at Ataturk University comparing two local anesthetic regimens for ultrasound-guided popliteal sciatic nerve block in adults undergoing elective distal lower extremity surgery. Sixty patients aged 18–65 (ASA I–III, BMI 18–35) will be randomized 1:1 to receive either 10 mL 2% lidocaine plus 10 mL 0.5% bupivacaine or 20 mL 0.5% bupivacaine alone prior to surgery. The primary outcome is onset time of sensory and motor blockade; secondary outcomes include block success rate, duration of sensory and motor block, postoperative opioid consumption, Numeric Rating Scale pain scores at 2, 4, 8, 12, and 24 hours, QoR-15 score, and incidence of rebound pain. Ultrasound guidance and standardized block technique will be used to ensure consistent administration across participants.
Why it matters
Potential benefit: If successful, the combination could provide quicker onset and prolonged postoperative analgesia, lowering opioid needs and improving early recovery.
How similar studies have gone: Prior studies suggest combining a short-acting agent like lidocaine with a long-acting agent like bupivacaine can speed onset while maintaining duration, but published results are mixed and not definitive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years * American Society of Anesthesiologists (ASA) physical status classification I, II, or III * Scheduled for elective distal lower extremity surgery (below-knee) * Body mass index (BMI) between 18 and 35 kg/m² * Provision of written informed consent Exclusion Criteria: * Refusal to participate in the study * Morbid obesity (BMI ≥35 kg/m²) * Known allergy or hypersensitivity to any local anesthetic agent * Severe cardiac, hepatic, or renal disease * Pre-existing neurological deficits or peripheral neuropathy * Use of anticoagulant therapy * History of prior surgery or significant scar tissue in the popliteal fossa * Pregnancy * Chronic opioid use at home
Where it's running
-
Ataturk University
Erzurum, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: AHMET MURAT YAYIK, MD, PhD — Ataturk University Faculty of Medicine, Department of Anesthesiology and Reanimation
- Study coordinator: AHMET MURAT YAYIK, MD, PhD
- Email: ahmetmuratyayik@gmail.com
- Phone: +95544259287
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PENG block plus local infiltration analgesia for anterior-approach hip replacement
This test sees if a motor-sparing PENG block combined with local infiltration around the hip controls pain as well as spinal anesthesia for adults having anterior‑approach hip replacement.
-
Comparing two nerve block techniques for pain relief after hip surgery
This study is testing which of two nerve block techniques helps people recover with less pain and fewer opioids after hip surgery.
-
Erector spinae plane block for managing pain after breast cancer surgery
This study is testing if a special nerve block combined with a medication can help reduce pain and improve recovery for women after breast cancer surgery.
-
Low-Volume PENG Block With Dexamethasone After Hip Replacement
This trial tests whether a smaller PENG block with dexamethasone provides similar pain relief but preserves quadriceps strength after hip replacement, compared with the standard-volume PENG block.
-
Analgesia after open inguinal hernia repair using intrathecal morphine or a transversalis fascia plane block
This trial tests whether intrathecal morphine or a ultrasound-guided transversalis fascia plane block can provide better pain relief after open inguinal hernia repair in adults.
-
Single-level vs two-level erector spinae plane block for breast surgery
This study tests whether a single-level ESPB provides similar pain relief to a two-level ESPB for adults undergoing breast surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.